WINDTREE THERAPEUTICS INC /DE/ Operating Lease Cost
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Operating Lease Cost of $514.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for the quarter ending 2019-12-31 was $212.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for the quarter ending 2019-09-30 was $212.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for the quarter ending 2019-06-30 was $227.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for the quarter ending 2019-03-31 was $238.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for fiscal 2024 was $514.00K, a 4.10% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for fiscal 2023 was $536.00K, a 22.54% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for fiscal 2022 was $692.00K, a 19.25% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, cost for fiscal 2021 was $857.00K, a 3.75% increase from fiscal 2020.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $514.00K 10-K · filed 2025-04-15 | |||
| 2023-12-31 | $536.00K 10-K · filed 2025-04-15 | |||
| 2022-12-31 | $692.00K 10-K · filed 2024-04-16 | |||
| 2021-12-31 | $857.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $826.00K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $424.00K derived: sum of 2 quarters · filed 2021-03-29 | $651.00K derived: sum of 3 quarters · filed 2021-03-29 | $889.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $212.00K 10-Q · filed 2019-11-14 | $439.00K derived: sum of 2 quarters · filed 2019-11-14 | $677.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $227.00K 10-Q · filed 2019-08-14 | $465.00K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $238.00K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |